Related Experiment Videos
Implementing tight glucose control after coronary artery bypass surgery.
Justine M Carr1, Frank W Sellke, Michelle Fey
1Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA. jcarr@bidmc.harvard.edu
The Annals of Thoracic Surgery
|August 27, 2005
Summary
Implementing a strict glucose control protocol for cardiac surgery patients significantly reduced mediastinitis rates. This approach, using a 110 mg/dL insulin trigger, proved effective in managing blood sugar and improving patient outcomes.
Area of Science:
- Cardiology
- Endocrinology
- Surgical Infection Prevention
Background:
- Tight glucose control offers clinical benefits for diabetic patients.
- Implementing such control in cardiac surgery presents challenges in definition, measurement, and variable assessment.
- Sternal wound infections are a concern in cardiac surgery patients.
Purpose of the Study:
- To implement and evaluate a tight glucose control protocol for cardiac surgery patients.
- To reduce sternal wound infections through improved glycemic management.
- To identify factors influencing glucose control in this patient population.
Main Methods:
- An interdisciplinary team developed and applied an insulin protocol for perioperative and intensive care unit management.
- Good glucose control was defined as maintaining blood glucose below 130 mg/dL for over 50% of measured time.
- The insulin initiation trigger was sequentially lowered from 150 mg/dL to 110 mg/dL.
Main Results:
- 90% of 818 coronary artery bypass grafting patients received insulin; 57% were not preoperatively diagnosed with diabetes.
- A protocol with a 110 mg/dL trigger was the strongest predictor of good glucose control (p < 0.001).
- Mediastinitis rates decreased from 1.6% to 0% during protocol implementation.
Conclusions:
- A standardized protocol and performance metrics are crucial for successful tight glucose control.
- This practice enhanced glycemic control and significantly reduced mediastinitis incidence.
- Patient-specific factors did not significantly impact glucose control under the protocol.